{"id":77287,"date":"2026-02-10T12:04:18","date_gmt":"2026-02-10T12:04:18","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/"},"modified":"2026-02-10T12:04:18","modified_gmt":"2026-02-10T12:04:18","slug":"apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/","title":{"rendered":"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results"},"content":{"rendered":"<div>\n<p>WALTHAM, Mass., Feb.  10, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Bbdy9P7yIivGUpEe5wsnTvXBYXDpE7GGPVCa8c3XGBUMvUwr4-J6hIIDnNNhx3l0XJRPc8ZsK3i23Mblw5mHtAvGALF6J9w0_aMTcTQAwsY=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>Apellis Pharmaceuticals<\/u><\/a>,\u00a0Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 at 8:30 a.m. ET.<\/p>\n<p>To access the live call by phone, please pre-register for the call <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=87hJFTBHwy2SxT0raj_vdGQn-d-qe4nWHAY4VHrox--c_hmJTsgB2DX04BiFlmyX8XoEbMlxyBff4eogbl5CpdKQhOhthSDc7k2Tp8dY3r_rgjNzDilH6F8xA779_8hMQZzPY5zw_HaxvFLmtnCIuzAOTnb-mz2dQ841mJ3CwTU=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>here<\/u><\/a>. A live audio webcast of the event and accompanying slides may also be accessed through the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SGdRtjoqJGYI_R7VhZMBvsoPOM3LcD4tGFe-D9avfbiG0gp_LTBhYAVoEWjF2qdbab4IJR_jWcx2FaNG8q45gJHAQ2fhYdsnOTFMtUOIouMJ2qqJBhin6V_opVhzJvGp\" rel=\"nofollow\" target=\"_blank\" title=\"website\">website<\/a>. A replay of the webcast will be available for 30 days following the event.<\/p>\n<p><strong><u>About Apellis<\/u><\/strong>\u00a0<br \/>Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_qN-yWJUBj8_usLjCHcC0o13lR3aJGGtyul0kstvnr20ziJJi1E88angEohS001cj_Y0M9DiPaEoss4YGcyHCyzlq7eh7f8ZQBf5c9Mdmx0P0fuWqNN0FeoBdEAIvujz2TAl06TZCia0Zg1ceHUXXQ4_rB4FkcqVQPGbeO5Swti1oggOsdi9znzUvxjaMD6KZTRQPUL4EClgnKPaT8KtkXD81tsHxI2fyn_VA3brI7DKM3lYZF6SG9wFLEin11Q3T67anFhoFrYDZdJdUTvr3A==\" rel=\"nofollow\" target=\"_blank\" title=\"\">http:\/\/apellis.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F7wMqws-4R5ht61U_iEGP_temPK8f-v4z64xwSCkf4vHDblUtebp31wbCMEhv622R7SKMzTVZQLc0XNnLCL-BRQkPE8X7b_JjLIH8tMw3_t2yeS0DwEs4-OpS5RlNUn4DsJeQKgpQ2Rs1UXXC3LzC9QaqIK39EmQEj-vhT4c3dQHKxEh-_0ZuJ8SjVN6XsXMIExIywJRF2CDh-6cS4vx6fUVIUyOOk6DYgqbJ3XeaPqX9gekrN6TbK0EcttzK1iYTEABnJkjsWC9qLhbmIPPzA==\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w5DUg1aCWgHRMfw1c7QGlbUFL9_gPhmlDFYyx3FNKgKydjP9KwDH847M_wMRDQBoBu3QVMK6PhlmSjwuG3WxQha4wR3yr9lZLo7xSiDvlWQJNgAOnCPx2mgx_otn3iDWsAuz-HrwTefW0IRGb652sbFw-ij1F2Ei5ModldYtFH0rMWkTxCzW87sQlZCJ-AEnO-CxgFkAQ-AnORyzWdLGGhhIrqWmhs4q2YZkDhCatM5sqkzjUohimLCffDUFJOWH3LxukjoGdjOSl7rcoOH_WQ==\" rel=\"nofollow\" target=\"_blank\" title=\"\u00a0\">\u00a0<\/a>and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VQM2skBWW3qf9Y3SFoY0FKbTgmqPBJ0F0ve9wXFRjue8JRTD2x5pXxk5Xs3AF-OhM8BriOzJRH_LgGGBl-V18gSuf-GIlRljUcbWNMbvFWnJ6aTz_4BiffLVvcLWc0LOhSU-1dhdorI6g0aU9K_4L4u0de4jGri-o7FfT8m6Shq3EckC89Jm307AswQvYrwMIRn7kxoaMj2C6o63GjzNKA==\" rel=\"nofollow\" target=\"_blank\" title=\"X\">X<\/a>.<\/p>\n<p><strong>Investor Contact:<\/strong><br \/>Eva Stroynowski<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eV_ImVfMHckvamSlPeDXIYnmddE_pW1Brsqa1eEkYOQq-HOLG0KRDMPyvdPqDXuJsbKazvJDlzhG8NKqsqnhr9TDgFjjt7pUjeIRdXG1d-Uj0r7cDUxfMj3RdMOS85ykQWgloP34EjO_bG_0Q5n9QZ68ui7gxFjAE5dWpBZQ6BKvX9LAh80i6f-v91bDrtuXtactrfn2PxWXLiTCp5m1iNK3n94CyR_3yAikENmJKmY=\" rel=\"nofollow\" target=\"_blank\" title=\"ir@apellis.com\">ir@apellis.com<\/a><br \/>617.938.6229<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2IwOTk5NWEtODQyZC00NjVjLTk3MWEtODRhZTBkMjExYTg4LTEwMzE1OTgtMjAyNi0wMi0xMC1lbg==\/tiny\/Apellis-Pharmaceuticals-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) &#8212; Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 at 8:30 a.m. ET. To access the live call by phone, please pre-register for the [&#8230;]\n","protected":false},"author":1,"featured_media":77288,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-77287","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) &#8212; Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS) today announced that the company will host a conf\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-10T12:04:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/02\/Apellis-Pharmaceuticals-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results\",\"datePublished\":\"2026-02-10T12:04:18+00:00\",\"dateModified\":\"2026-02-10T12:04:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/\"},\"wordCount\":241,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/\",\"name\":\"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-02-10T12:04:18+00:00\",\"dateModified\":\"2026-02-10T12:04:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results","og_description":"WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) &#8212; Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS) today announced that the company will host a conf","og_url":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-02-10T12:04:18+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/02\/Apellis-Pharmaceuticals-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results","datePublished":"2026-02-10T12:04:18+00:00","dateModified":"2026-02-10T12:04:18+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/"},"wordCount":241,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/","url":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/","name":"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-02-10T12:04:18+00:00","dateModified":"2026-02-10T12:04:18+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/apellis-pharmaceuticals-to-host-conference-call-on-february-24-2026-to-discuss-fourth-quarter-and-full-year-2025-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/77287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=77287"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/77287\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/77288"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=77287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=77287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=77287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}